Ladenburg Thalmann Financial Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$953K Buy
2019
Q3
$514K Buy
2019
Q2
$527K Buy
2019
Q1
$395K Buy
2018
Q4
$297K Buy
2018
Q3
$380K Buy
2018
Q2
$186K Hold
2018
Q1
$186K Buy
2017
Q4
$22K Buy
2017
Q3
$11K Buy
2017
Q2
$2K Hold
2017
Q1
$2K Buy